arrow
D

Didier Meseure

unicancer
H指数:31
被引数:3,702

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TFEB triggers a matrix degradation and invasion program in triple-negative breast cancer cells upon mTORC1 repression

TFEB在mTORC1受抑制时,触发了三阴性乳腺癌细胞的基质降解和侵袭程序。

2024-12-010
OAAI
Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer

解读乳腺癌中免疫抑制性成纤维细胞的空间景观和可塑性

2024-04-018
OAAI
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial

Nivolumab联合放化疗治疗局部晚期宫颈癌: NICOL 1期试验

2023-06-2224
OAAI
Evolution of synchronous female bilateral breast cancers and response to treatment
2023-03-068
OAAI
A catalog of numerical centrosome defects in epithelial ovarian cancers
2022-09-0711
OAAI
Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer

脂质相关巨噬细胞由癌症相关成纤维细胞诱导并介导乳腺癌的免疫抑制

2022-07-21109
OA
Ret kinase-mediated mechanical induction of colon stem cells by tumor growth pressure stimulates cancer progression in vivo
2022-02-178
OAAI
Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients
2021-04-1264
OAAI
The Expression of Anti-Mullerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer
2021-04-079
OAAI
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance
2020-08-1391
OAAI
Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients

乳腺癌患者引流淋巴结中肿瘤浸润与Treg积累相关

2020-06-29140
OAAI
Impact of body mass index (BMI) on the predictive and prognostic value of stromal tumor-infiltrating lymphocytes (sTIL) in triple-negative breast cancer (TNBC) patients treated with neoadjuvant chemotherapy (NACT)
2020-02-150
PRE
Immune gene expression in head and neck squamous cell carcinoma patients

头颈部鳞状细胞癌患者免疫基因表达的研究

2019-11-0149
OAAI
PDX models of ER plus endocrine-resistant metastatic breast cancer identify Polo-like kinase 1 (PLK1) as a therapeutic target
2019-07-010
PRE
Anti-Mullerian hormone type II receptor (AMHRII) found expressed in human non-gynecological solid tumors, suggesting potential broader applications for anti-AMHRII-based therapy
2018-07-011
PRE